Concepedia
Statistics
Publications
11
Citations
1.1K
H-Index
Active since
2006
Affiliations
The Ohio State University(Current)
The University of Texas MD Anderson Cancer Center
AstraZeneca (United States)
AstraZeneca (United Kingdom)
Memorial Sloan Kettering Cancer Center
Murali V.P. Nadella is an author at The Ohio State University specializing in oncology, medicine, and pathology.
Top concepts
MedicineOncologyPathologyImmunologyLung CancerCell BiologyTumor BiologyHistopathologyCancer ResearchVeterinary Science
Publications per year
2006–2024
AZD9150, a next-generation antisense oligonucleotide inhibitor of <i>STAT3</i> with early evidence of clinical activity in lymphoma and lung cancer
David S. Hong, Razelle Kurzrock, Youngsoo Kim et al. · Science Translational Medicine · 2015 · 428 citations · Full text
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
Matthew J. Reilley, Patricia McCoon, Carl Cook et al. · Journal for ImmunoTherapy of Cancer · 2018 · 275 citations · Full text
New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft
Bruce E. LeRoy, Nanda K. Thudi, Murali V.P. Nadella et al. · The Prostate · 2006 · 73 citations
A novel canine lymphoma cell line: A translational and comparative model for lymphoma research
William C. Kisseberth, Murali V.P. Nadella, Matthew Breen et al. · Leukemia Research · 2007 · 50 citations
Lymphoid Neoplasia, Medicine, Lymphoma Research +8
Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions
Nanda K. Thudi, Chelsea K. Martin, Murali V.P. Nadella et al. · The Prostate · 2008 · 48 citations · Full text
1–5 of 11